A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome
PHASE3CompletedINTERVENTIONAL
Enrollment
104
Participants
Timeline
Start Date
April 30, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Conditions
Menopausal Syndrome
Interventions
DRUG
MELSMON
DRUG
UNCNT
Trial Locations (2)
Unknown
Inha Univ.Hospital,, Incheon
Korea University Medical center Anam Hospital, Seoul
All Listed Sponsors
lead
Unimed Pharmaceuticals
INDUSTRY
NCT01931748 - A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome | Biotech Hunter | Biotech Hunter